Some users may experience mild skin redness or temporary irritation at the application site, particularly during the first few uses
Not recommended for patients under 18 years
With over 80 years of experience, JW brings deep development and commercial expertise in metabolic diseasesa key factor in our decision to partner with JW." Young-sub Shin, CEO of JW Pharmaceutical, commented: "This agreement represents a significant milestone in expanding our product portfolio within the rapidly growing therapeutic area of metabolic diseases, particularly diabetes and obesity
I missed two weekly doses total before I felt well enough to resume
The FDA has established an import alert to help block GLP-1 active pharmaceutical ingredients with potential quality concerns from entering the US supply chain, while emphasizing that compounded drugs should only be used when a patients medical needs cannot be met by an FDA-approved alternative
Patients prescribed GLP-1 receptor agonists should: Receive proper training on injection technique Be monitored regularly for efficacy and adverse effects Report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app) Understand that these medicines are part of a comprehensive treatment plan including diet and lifestyle modifications The synthetic manufacturing process and stringent regulatory oversight ensure that GLP-1 medicines meet the highest pharmaceutical standards, with no risk of venom-related contamination or variability